|Mr. Robert Read BComm(Mgt), BA(Psych), GAICD||MD, CEO & Exec. Director||313,12k||N/A||N/A|
|Mr. Joshua Swinnerton MEI, GradCert Eng., BE, BCS(Hons).||Founder, Chief Product Officer & Exec. Director||282,7k||N/A||N/A|
|Mr. Simon Glover||Chief Financial Officer||216,94k||N/A||N/A|
|Mr. Carlo Campiciano||Company Sec.||182,19k||N/A||N/A|
|Mr. Craig Schnuriger||Interim Chief Technology Officer||N/A||N/A||N/A|
|Ms. Naomi Lawrie||Company Sec. & Gen. Counsel||N/A||N/A||N/A|
|Jennifer Duraisingam||Corp. Communications Mang.||N/A||N/A||N/A|
|Mr. Theo Antonopoulos||Head of Sales & Marketing||N/A||N/A||N/A|
|Ms. Ruba El-Afifi||Exec. Gen. Mang. of People & Culture||N/A||N/A||N/A|
|Mr. Jamal Butt||Head of Commercial||N/A||N/A||N/A|
MedAdvisor Limited, together with its subsidiaries, develops and delivers software for personal medication management in Australia. It develops and deploys the MedAdvisor, a medication and adherence platform that connects health professionals with patients using mobile and web technologies. MedAdvisor Limited was incorporated in 2010 and is headquartered in Camberwell, Australia.
MedAdvisor Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.